CS logo
small CS logo
National Cancer Institute; Department of Thoracic Surgery and Oncology

Vilnius, Lithuania

About National Cancer Institute; Department of Thoracic Surgery and Oncology


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
No rows

Clinical Trials at National Cancer Institute; Department of Thoracic Surgery and Oncology


During the past decade, National Cancer Institute; Department of Thoracic Surgery and Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at National Cancer Institute; Department of Thoracic Surgery and Oncology


According to Clinical.Site data, the most researched conditions in "National Cancer Institute; Department of Thoracic Surgery and Oncology" are "Hepatocellular Carcinoma" (1 trials), "NSCLC" (1 trials), "Non-Small Cell Lung Cancer" (1 trials), "Small Cell Lung Cancer" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "National Cancer Institute; Department of Thoracic Surgery and Oncology" in a lesser frequency.

Clinical Trials Intervention Types at National Cancer Institute; Department of Thoracic Surgery and Oncology


Most popular intervention types in "National Cancer Institute; Department of Thoracic Surgery and Oncology" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Alectinib" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at National Cancer Institute; Department of Thoracic Surgery and Oncology


The vast majority of trials in "National Cancer Institute; Department of Thoracic Surgery and Oncology" are 2 trials for "All" genders.

Clinical Trials Status at National Cancer Institute; Department of Thoracic Surgery and Oncology


Currently, there are NaN active trials in "National Cancer Institute; Department of Thoracic Surgery and Oncology". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in National Cancer Institute; Department of Thoracic Surgery and Oncology, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in National Cancer Institute; Department of Thoracic Surgery and Oncology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status